Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.

Kidney international - 1 May 2005

Monico Carla G, Rossetti Sandro, Olson Julie B, Milliner Dawn S

Abstract excerpt

BACKGROUND: Pyridoxine (VB6) response in type I primary hyperoxaluria (PHI) is variable, with nearly equal numbers of patients showing partial to complete reductions in oxaluria, and resistance. Because high urine oxalate concentrations cause stones and renal injury, reduction in urine oxalate excretion is deemed favorable. Mechanisms of VB6 action on hepatic alanine:glyoxylate aminotransferase (AGT), the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child, Preschool
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Homozygote

Share to Hyperoxaluria, Primary

Share to Pyridoxine

Share to Transaminases

Source

Identifiers

PMID: 15840016
DOI: 10.1111/j.1523-1755.2005.00267.x

Genes

AGT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.PMID 15840016Read ↗

Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria.Semantic proximity Read ↗

[From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].Semantic proximity Read ↗

Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.Semantic proximity Read ↗

Molecular Aetiology of Primary Hyperoxaluria Type 1Semantic proximity Read ↗

Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.Semantic proximity Read ↗

Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.Semantic proximity Read ↗

Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center.Semantic proximity Read ↗

Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.Semantic proximity Read ↗

Primary hyperoxalurias: diagnosis and treatment.Semantic proximity Read ↗

Molecular aetiology of primary hyperoxaluria and its implications for clinical management.Semantic proximity Read ↗

Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.Semantic proximity Read ↗

A molecular journey on the pathogenesis of primary hyperoxaluria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.